This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The State University of New York, General Sentiment, Inc.. Active years: 2013-2021.
Company Filing History:
Years Active: 2013-2021
Title: The Innovations of Steve Skiena
Introduction
Steve Skiena is a prominent inventor based in Setauket, NY (US), known for his significant contributions to the field of virology and vaccine development. With a total of four patents to his name, Skiena has made remarkable strides in creating innovative solutions for public health.
Latest Patents
Among his latest patents, Skiena has developed attenuated viruses useful for vaccines. This invention provides an attenuated virus that comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome. The substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. Additionally, the invention outlines a method of synthesizing the instant attenuated virus. Furthermore, it provides a method for preventing a subject from becoming afflicted with a virus-associated disease by administering a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.
Another notable patent by Skiena involves methods of making modified viral genomes. Similar to his previous invention, this patent also focuses on an attenuated virus with a modified viral genome containing nucleotide substitutions. The applications of this invention are crucial for developing effective vaccines and enhancing public health measures.
Career Highlights
Steve Skiena has had a distinguished career, working with esteemed institutions such as the State University of New York and General Sentiment, Inc. His work has significantly impacted the field of virology and vaccine research, showcasing his dedication to advancing medical science.
Collaborations
Throughout his career, Skiena has collaborated with notable colleagues, including Eckard Wimmer and Steffen Mueller. These collaborations have further enriched his research and contributed to the development of innovative solutions in virology.
Conclusion
Steve Skiena's contributions to the field of vaccine development and virology are noteworthy. His innovative patents and collaborations reflect his commitment to improving public health through scientific advancements. His work continues to inspire future generations of inventors and researchers.